Surgical Science Sweden AB Stock Nasdaq Stockholm
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- SEK | - |
04-15 | Gisli Hennermark to Leave His Position as CEO of Surgical Science Sweden AB | CI |
03-12 | Surgical Science Sweden to Step Down; Search for Successor Starts | MT |
Sales 2024 * | 939M 88.95M 121M | Sales 2025 * | 1.16B 110M 150M | Capitalization | 7.2B 683M 931M |
---|---|---|---|---|---|
Net income 2024 * | 186M 17.62M 24.03M | Net income 2025 * | 287M 27.2M 37.08M | EV / Sales 2024 * | 6.8 x |
Net cash position 2024 * | 818M 77.48M 106M | Net cash position 2025 * | 1.1B 104M 142M | EV / Sales 2025 * | 5.27 x |
P/E ratio 2024 * |
38.6
x | P/E ratio 2025 * |
25.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.33% |
Latest transcript on Surgical Science Sweden AB
Managers | Title | Age | Since |
---|---|---|---|
Anders Larsson
FOU | Founder | 51 | 97-07-23 |
Gisli Hennermark
CEO | Chief Executive Officer | 52 | 14-12-31 |
Director of Finance/CFO | 54 | 17-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roland Bengtsson
CHM | Chairman | 69 | 04-12-31 |
Director/Board Member | 57 | 16-12-31 | |
Director/Board Member | 49 | 21-05-11 |
1st Jan change | Capi. | |
---|---|---|
+5.91% | 32.95B | |
+19.28% | 7.87B | |
+33.25% | 4.35B | |
-29.52% | 2.67B | |
-13.29% | 1.5B | |
-28.02% | 1.27B | |
-33.09% | 1.16B | |
+11.35% | 996M | |
-38.47% | 859M |